These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 194649)

  • 1. Polio vaccines and polioviruses.
    Br Med J; 1977 Jun; 1(6077):1617-8. PubMed ID: 194649
    [No Abstract]   [Full Text] [Related]  

  • 2. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
    Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
    Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new combined inactivated DPT-polio vaccine.
    Drucker J; Soula G; Diallo O; Fabre P
    Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 6. Infectious vaccines.
    Ross DW
    Arch Pathol Lab Med; 1998 Jan; 122(1):100-1. PubMed ID: 9448028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advantages and disadvantages of antipoliomyelitis vaccines prepared with live and killed viruses].
    Melnick JL
    Bol Oficina Sanit Panam; 1980 Jun; 88(6):507-29. PubMed ID: 6448065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Case of poliomyelitis in unvaccinated children in contact with persons vaccinated with attenuated virus].
    Kostrzewski JM
    Przegl Epidemiol; 1973; 27(2):259-65. PubMed ID: 4720593
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of poliovirus since introduction of attenuated vaccine.
    Wyatt HV
    Br Med J; 1977 Aug; 2(6085):518. PubMed ID: 890381
    [No Abstract]   [Full Text] [Related]  

  • 10. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
    Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of immunization of mice with live viral vaccines on bone marrow cell chromosomes in 1st generation progeny].
    Gorshunova LP; Mikhaĭlova GR; Cherkeziia SE
    Tsitol Genet; 1975; 9(6):542-5. PubMed ID: 1221580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of children to a single dose of oral or inactivated polio vaccine.
    Magrath D; Bainton D; Freeman M
    Dev Biol Stand; 1981; 47():223-6. PubMed ID: 7227651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of concentrated inactivated polio vaccine in a simplified immunization program.
    Fillastre C; Emmou C; Meyran M; Schlumberger M; Guérin N
    Dev Biol Stand; 1981; 47():207-13. PubMed ID: 6262148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Will Salk's polio vaccination be used again?].
    Stickl H
    Fortschr Med; 1978 Apr; 96(13):688-94. PubMed ID: 631710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.